news
Scientists identify innate lymphoid cells (ILCs) as possible targets for…
25 February 2020 | By Hannah Balfour (Drug Target Review)
Scientists identify innate lymphoid cells (ILCs) as possible targets for immunotherapies as their activation makes murine pancreatic tumours sensitive to PD-1 checkpoint inhibitors.